In vivo evaluation of novel chitosan graft polymeric micelles for delivery of paclitaxel

References

• Bae, Y., Diezi, T.A., Zhao, A., Kwon, G.S. (2007). Mixed polymeric micelles for combination cancer chemotherapy through the concurrent delivery of multiple chemotherapeutic agents. J Contr Rel. 122:324–30.
   PubMed Web of Science ®Google Scholar
• Chen, H., Wang, Y., Xu, J., Ji, J., Zhang, J., Hu, Y., Gu, Y. (2008). Non-invasive near infrared fluorescence imaging of CdHgTe quantum dots in mouse model. J Fluoresc. 18:801–11.
   PubMed Web of Science ®Google Scholar
• Cho, Y.W., Park, S.A., Han, T.H., Son, D.H., Park, J.S., Oh, S.J., Moon, D.H., Cho, K.J., Ahn, C.H., Byun, Y., Kim, I.S., Kwon, I.C., Kim, S.Y. (2007). In vivo tumor targeting and radionuclide imaging with self-assembled nanoparticles: mechanisms, key factors, and their implications. Biomaterials. 28:1236–47.
   PubMed Web of Science ®Google Scholar
• Crosasso, P., Ceruti, M., Brusa, P., Arpicco, S., Dosio, F., Cattel, L. (2000). Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. J Contr Rel. 63:19–30.
   PubMed Web of Science ®Google Scholar
• Danson, S., Ferry, D., Alakhov, V., Margison, J., Kerr, D., Jowle, D., Brampton, M., Halbert, G., Ranson, M. (2004). Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer. Br J Cancer. 90;2085–91.
   PubMed Web of Science ®Google Scholar
• Desai, N., Trieu, V., Yao, Z., Louie, L., Ci, S., Yang, A., Tao, C., De, T., Beals, B., Dykes, D., Noker, P., Yao, R., Labao, E., Hawkins, M., Soon-Shiong, P. (2006). Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Clin Cancer Res. 12:1317–24.
   PubMed Web of Science ®Google Scholar
• Dhanikula, A.B., Singh, D.R., Panchagnula, R. (2005). In vivo pharmacokinetic and tissue distribution studies in mice of alternative formulations for local and systemic delivery of Paclitaxel: gel, film, prodrug, liposomes and micelles. Curr Drug Deliv. 2:35–44.
   PubMedGoogle Scholar
• Hruby, M., Konak, C., Ulbrich, K. (2005). Polymeric micellar pH-sensitive drug delivery system for doxorubicin. J Contr Rel. 103:137–48.
   PubMed Web of Science ®Google Scholar
• Huh, K.M., Lee, S.C., Cho, Y.W., Lee, J., Jeong, J.H., Park, K. (2005). Hydrotropic polymer micelle system for delivery of paclitaxel. J Contr Rel. 101:59–68.
   PubMed Web of Science ®Google Scholar
• Huh, K.M., Min, H.S., Lee, S.C., Lee, H.J., Kim, S., Park, K. (2008). A new hydrotropic block copolymer micelle system for aqueous solubilization of paclitaxel. J Contr Rel. 126:122–9.
   PubMed Web of Science ®Google Scholar
• Huo, M., Zhang, Y., Zhou, J., Zou, A., Yu, D., Wu, Y., Li, J., Li, H. (2010). Synthesis and characterization of low-toxic amphiphilic chitosan derivatives and their application as micelle carrier for antitumor drug. Int J Pharmaceut. 394:162–73.
   PubMed Web of Science ®Google Scholar
• Ibrahim, N.K., Desai, N., Legha, S., Soon-Shiong, P., Theriault, R.L., Rivera, E., Esmaeli, B., Ring, S.E., Bedikian, A., Hortobagyi, G.N., Ellerhorst, J.A. (2002). Phase I and pharmacokinetic study of ABI-007, a Cremophor-free, protein-stabilized, nanoparticle formulation of paclitaxel. Clin Cancer Res. 8:1038–44.
   PubMed Web of Science ®Google Scholar
• Ibrahim, N.K., Samuels, B., Page, R., Doval, D., Patel, K.M., Rao, S.C., Nair, M.K., Bhar, P., Desai, N., Hortobagyi, G.N. (2005). Multicenter phase II trial of ABI-007, an albumin-bound paclitaxel, in women with metastatic breast cancer. J Clin Oncol. 23:6019–26.
   PubMed Web of Science ®Google Scholar
• Kim, S.C., Kim, D.W., Shim, Y.H., Bang, J.S., Oh, H.S., Wan Kim, S., Seo, M.H. (2001). In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J Contr Rel. 72:191–202.
   PubMed Web of Science ®Google Scholar
• Kwon, G.S. (2003). Polymeric micelles for delivery of poorly water-soluble compounds. Crit Rev Ther Drug Carrier Syst. 20:357–3.
   PubMed Web of Science ®Google Scholar
• Kwon, G.S., Yokoyama, M., Okano, T., Sakurai, Y., Kataoka, K. (1993). Biodistribution of micelle-forming polymer-drug conjugates. Pharm Res. 10:970–4.
   PubMed Web of Science ®Google Scholar
• Lee, A.L., Wang, Y., Cheng, H.Y., Pervaiz, S., Yang, Y.Y. (2009). The co-delivery of paclitaxel and Herceptin using cationic micellar nanoparticles. Biomaterials. 30:919–27.
   PubMed Web of Science ®Google Scholar
• Lee, E.S., Gao, Z., Kim, D., Park, K., Kwon, I.C., Bae, Y.H. (2008). Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance. J Contr Rel. 129:228–36.
   PubMed Web of Science ®Google Scholar
• Li, H., Liu, J., Ding, S., Zhang, C., Shen, W., You, Q. (2009). Synthesis of novel pH-sensitive chitosan graft copolymers and micellar solubilization of paclitaxel. Int J Biol Macromol. 44:249–56.
   PubMed Web of Science ®Google Scholar
• Liggins, R.T., Burt, H.M. (2004). Paclitaxel-loaded poly(L-lactic acid) microspheres 3: blending low and high molecular weight polymers to control morphology and drug release. Int J Pharm. 282:61–71.
   PubMed Web of Science ®Google Scholar
• Liu, J., Li, H., Jiang, X., Zhang, C., Ping, Q. (2010). Novel pH-sensitive chitosan-derived micelles loaded with paclitaxel. Carbohydr Polym. 82:432–9.
   Web of Science ®Google Scholar
• Matsumoto, J., Nakada, Y., Sakurai, K., Nakamura, T., Takahashi, Y. (1999). Preparation of nanoparticles consisted of poly(L-lactide)-poly(ethylene glycol)-poly(L-lactide) and their evaluation in vitro. Int J Pharm. 185:93–101.
   PubMed Web of Science ®Google Scholar
• Matsumura, Y., Hamaguchi, T., Ura, T., Muro, K., Yamada, Y., Shimada, Y., Shirao, K., Okusaka, T., Ueno, H., Ikeda, M., Watanabe, N. (2004). Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br J Cancer. 91:1775–81.
   PubMed Web of Science ®Google Scholar
• Mizumura, Y., Matsumura, Y., Yokoyama, M., Okano, T., Kawaguchi, T., Moriyasu, F., Kakizoe, T. (2002). Incorporation of the anticancer agent KRN5500 into polymeric micelles diminishes the pulmonary toxicity. Jpn J Cancer Res. 93:1237–43.
   PubMedGoogle Scholar
• Ooya, T., Lee, J., Park, K. (2003). Effects of ethylene glycol-based graft, star-shaped, and dendritic polymers on solubilization and controlled release of paclitaxel. J Contr Rel. 93:121–7.
   PubMed Web of Science ®Google Scholar
• Qu, G., Yao, Z., Zhang, C., Wu, X., Ping, Q. (2009). PEG conjugated N-octyl-O-sulfate chitosan micelles for delivery of paclitaxel: in vitro characterization and in vivo evaluation. Eur J Pharm Sci. 37:98–105.
   PubMed Web of Science ®Google Scholar
• Rapoport, N. (2007). Physical stimuli-responsive polymeric micelles foranti-cancer drug delivery. Prog Polym Sci. 32:962–90.
   Web of Science ®Google Scholar
• Rowinsky, E.K., Donehower, R.C. (1993). The clinical pharmacology of paclitaxel (Taxol). Semin Oncol. 2016–25.
   Google Scholar
• Sawant, R.R., Torchilin, V.P. (2009). Enhanced cytotoxicity of TATp-bearing paclitaxel-loaded micelles in vitro and in vivo. Int J Pharm. 374:114–8.
   PubMed Web of Science ®Google Scholar
• Sawant, R.R., Vaze, O., Rockwell, K., Torchilin, V.P. (2010). Palmitoyl ascorbate-modified liposomes as nanoparticle platform for ascorbate-mediated cytotoxicity and paclitaxel co-delivery. Eur J Pharm Biopharm. 75:321–326.
   PubMed Web of Science ®Google Scholar
• Sonnichsen, D.S., Relling, M.V. (1994). Clinical pharmacokinetics of paclitaxel. Clin Pharmacokinet. 27:256–69.
   PubMed Web of Science ®Google Scholar
• Spencer, C.M., Faulds, D. (1994). Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer. Drugs. 48:794–847.
   PubMed Web of Science ®Google Scholar
• Szebeni, J., Muggia, F.M., Alving, C.R. (1998). Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study. J Natl Cancer Inst. 90:300–6.
   PubMed Web of Science ®Google Scholar
• Torchilin, V. (2010). Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev. (In press).
   Google Scholar
• Torchilin, V.P. (2001). Structure and design of polymeric surfactant-based drug delivery systems. J Contr Rel. 73:137–72.
   PubMed Web of Science ®Google Scholar
• Torchilin, V.P. (2007). Micellar nanocarriers: pharmaceutical perspectives. Pharm Res. 24:1–16.
   PubMed Web of Science ®Google Scholar
• van Zuylen, L., Karlsson, M.O., Verweij, J., Brouwer, E., de Bruijn, P., Nooter, K., Stoter, G., Sparreboom, A. (2001). Pharmacokinetic modeling of paclitaxel encapsulation in Cremophor EL micelles. Cancer Chemother Pharmacol. 47:309–18.
   PubMed Web of Science ®Google Scholar
• Wanjun, T., Cunxin, W., Donghua, C. (2005). Kinetic studies on the pyrolysis of chitin and chitosan. Polymer Degr Stab. 87:389–94.
   Web of Science ®Google Scholar
• Xie, Z., Guan, H., Chen, X., Lu, C., Chen, L., Hu, X., Shi, Q., Jing, X. (2007). A novel polymer-paclitaxel conjugate based on amphiphilic triblock copolymer. J Contr Rel. 117:210–6.
   PubMed Web of Science ®Google Scholar
• Yang, T., Choi, M.K., Cui, F.D., Kim, J.S., Chung, S.J., Shim, C.K., Kim, D.D. (2007). Preparation and evaluation of paclitaxel-loaded PEGylated immunoliposome. J Contr Rel. 120:169–77.
   PubMed Web of Science ®Google Scholar
• Yokoyama, M., Miyauchi, M., Yamada, N., Okano, T., Sakurai, Y., Kataoka, K., Inoue, S. (1990). Characterization and anticancer activity of the micelle-forming polymeric anticancer drug adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. Cancer Res. 50:1693–700.
   PubMed Web of Science ®Google Scholar
• Yokoyama, M., Okano, T., Sakurai, Y., Ekimoto, H., Shibazaki, C., Kataoka, K. (1991). Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res. 51:3229–36.
   PubMed Web of Science ®Google Scholar
• Zhang, C., Ping, Q., Zhang, H., Jian, S. (2003). Preparation of N-alkyl-O-sulfate chitosan derivatives and micellar solubilization of taxol. Carbohydr Polymers. 54:137–44.
   Web of Science ®Google Scholar
• Zhang, C., Qu, G., Sun, Y., Wu, X., Yao, Z., Guo, Q., Ding, Q., Yuan, S., Shen, Z., Ping, Q., Zhou, H. (2008a). Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. Biomaterials. 29:1233–41.
   PubMed Web of Science ®Google Scholar
• Zhang, C., Qu, G., Sun, Y., Yang, T., Yao, Z., Shen, W., Shen, Z., Ding, Q., Zhou, H., Ping, Q. (2008b). Biological evaluation of N-octyl-O-sulfate chitosan as a new nano-carrier of intravenous drugs. Eur J Pharm Sci. 33:415–23.
   PubMed Web of Science ®Google Scholar
• Zhang, J., Chen, H., Xu, L., Gu, Y. (2008c). The targeted behavior of thermally responsive nanohydrogel evaluated by NIR system in mouse model. J Contr Rel. 131:34–40.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., Tang, L., Sun, L., Bao, J., Song, C., Huang, L., Liu, K., Tian, Y., Tian, G., Li, Z., Sun, H., Mei, L. (2010). A novel paclitaxel-loaded poly(epsilon-caprolactone)/Poloxamer 188 blend nanoparticle overcoming multidrug resistance for cancer treatment. Acta Biomater. 6:2045–52.
   PubMed Web of Science ®Google Scholar
• Zhang, Z., Feng, S.S. (2006). The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles. Biomaterials. 27:4025–33.
   PubMed Web of Science ®Google Scholar
• Zhu, C., Jung, S., Luo, S., Meng, F., Zhu, X., Park, T.G., Zhong, Z. (2010). Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA-PCL-PDMAEMA triblock copolymers. Biomaterials. 31:2408–16.
   PubMed Web of Science ®Google Scholar